AI Chat Paper
Note: Please note that the following content is generated by AMiner AI. SciOpen does not take any responsibility related to this content.
{{lang === 'zh_CN' ? '文章概述' : 'Summary'}}
{{lang === 'en_US' ? '中' : 'Eng'}}
Chat more with AI
PDF (717.5 KB)
Collect
Submit Manuscript AI Chat Paper
Show Outline
Outline
Show full outline
Hide outline
Outline
Show full outline
Hide outline
Short Communication | Open Access

AluScanCNV2: An R package for copy number variation calling and cancer risk prediction with next-generation sequencing data

Taobo HuaSi ChenaAta UllahaHong Xuea,b,( )
Division of Life Science, Applied Genomics Centre and Centre for Statistical Science, Hong Kong University of Science and Technology, Clear Water Bay, Hong Kong
School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China

Peer review under responsibility of Chongqing Medical University.

Show Author Information

Abstract

The usage of next-generation sequencing (NGS) to detect copy number variation (CNV) is widely accepted in cancer research. Based on an AluScanCNV software developed by us previously, an AluScanCNV2 software has been developed in the present study as an R package that performs CNV detection from NGS data obtained through AluScan, wholegenome sequencing or other targeted NGS platforms. Its applications would include the expedited usage of somatic CNVs for cancer subtyping, and usage of recurrent germline CNVs to perform machine learning-assisted prediction of a test subject’s susceptibility to cancer.

References

1

Zarrei M, MacDonald JR, Merico D, Scherer SW. A copy number variation map of the human genome. Nat Rev Genet. 2015;16(3):172-183.

2

Nagao Y. Copy number variations play important roles in heredity of common diseases: a novel method to calculate heritability of a polymorphism. Sci Rep. 2015;5:17156. https://doi.org/10.1038/srep17156.

3

Xie C, Tammi MT. CNV-seq, a new method to detect copy number variation using high-throughput sequencing. BMC Bioinf. 2009;10:80. https://doi.org/10.1186/1471-2105-10-80.

4

Yang JF, Ding XF, Chen L, et al. Copy number variation analysis based on AluScan sequences. J Clin Bioinf. 2014;4(1):15.

5

Ding X, Tsang SY, Ng SK, Xue H. Application of machine learning to development of copy number variation-based prediction of cancer risk. Genomics Insights. 2014;7(Supplementary Files 15002):1-11.

6

Kuhn M. Caret: Classification and Regression Training. Astrophysics Source Code Library; 2015.

7

Mei L, Ding X, Tsang SY, et al. AluScan: a method for genome-wide scanning of sequence and structure variations in the human genome. BMC Genom. 2011;12:564. https://doi.org/10.1186/1471-2164-12-564.

8

Kumar Y, Yang J, Hu T, et al. Massive interstitial copy-neutral loss-of-heterozygosity as evidence for cancer being a disease of the DNA-damage response. Bmc Med Genomics. 2015;8:42. https://doi.org/10.1186/s12920-015-0104-2.

9

Hu T, Kumar Y, Shazia I, et al. Forward-reverse mutations in stages of cancer development. bioRxiv. 2017:198309. https://doi.org/10.1101/198309.

10

Genomes Project C, Auton A, Brooks LD, et al. A global reference for human genetic variation. Nature. 2015;526(7571):68-74.

11

Greenblum S, Carr R, Borenstein E. Extensive strain-level copynumber variation across human gut microbiome species. Cell. 2015;160(4):583-594.

Genes & Diseases
Pages 43-46
Cite this article:
Hu T, Chen S, Ullah A, et al. AluScanCNV2: An R package for copy number variation calling and cancer risk prediction with next-generation sequencing data. Genes & Diseases, 2019, 6(1): 43-46. https://doi.org/10.1016/j.gendis.2018.09.001

229

Views

2

Downloads

10

Crossref

N/A

Web of Science

9

Scopus

0

CSCD

Altmetrics

Received: 06 June 2018
Accepted: 04 September 2018
Published: 08 September 2018
© 2018, Chongqing Medical University.

This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).

Return